Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.

Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M.

Dis Colon Rectum. 1997 Dec;40(12):1465-71.

PMID:
9407986
2.

Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.

Rosenberg R, Friederichs J, Gertler R, Hoos A, Mueller J, Nahrig J, Nekarda H, Siewert JR.

Int J Colorectal Dis. 2004 Sep;19(5):430-7. Epub 2004 Jan 10.

PMID:
14716495
3.

Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.

Choi HJ, Choi YY, Hong SH.

Dis Colon Rectum. 2002 Jun;45(6):750-5; discussion755-6.

PMID:
12072625
4.

Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Milsmann C, Füzesi L, Heinmöller E, Krause P, Werner C, Becker H, Horstmann O.

Langenbecks Arch Surg. 2008 Jan;393(1):49-58. Epub 2007 Sep 18.

PMID:
17876601
5.

Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.

Messerini L, Cianchi F, Cortesini C, Comin CE.

Hum Pathol. 2006 Oct;37(10):1259-67. Epub 2006 Jul 26.

PMID:
16949928
6.

Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma.

Vazquez-Sequeiros E, Wang L, Burgart L, Harmsen W, Zinsmeister A, Allen M, Jondal M, Wiersema M.

Gastroenterology. 2002 Jun;122(7):1815-21.

PMID:
12055589
8.

Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.

Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ, Lee MJ, Kim WH, Park JG.

J Surg Oncol. 2006 Jan 1;93(1):13-8; discussion 18-9.

PMID:
16353185
9.

Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.

Passlick B, Izbicki JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, Schweiberer L, Riethmüller G, Pantel K.

J Clin Oncol. 1994 Sep;12(9):1827-32.

PMID:
8083707
10.

Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.

Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, Cochran AJ.

J Natl Cancer Inst. 1993 Mar 17;85(6):493-8.

PMID:
7680382
11.

Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.

Cianchi F, Messerini L, Comin CE, Boddi V, Perna F, Perigli G, Cortesini C.

Dis Colon Rectum. 2007 Sep;50(9):1332-41.

PMID:
17429709
12.

[Significance of occult lymphatic tumor spread in pancreatic cancer].

Milsmann C, Füzesi L, Werner C, Becker H, Horstmann O.

Chirurg. 2005 Nov;76(11):1064-72. German.

PMID:
15971035
13.

Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.

Weitz J, Kienle P, Magener A, Koch M, Schrödel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth C, von Knebel Doeberitz M.

Clin Cancer Res. 1999 Jul;5(7):1830-6.

14.

Prognostic significance of occult lymph node metastases in node-negative breast cancer.

Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ.

Ann Surg Oncol. 1997 Sep;4(6):447-51.

PMID:
9309332
15.
16.

[Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].

Broll R, Lembcke K, Stock C, Zingler M, Duchrow M, Schimmelpenning H, Strik M, Muller G, Kujath P, Bruch HP.

Langenbecks Arch Chir. 1996;381(1):51-8. German.

PMID:
8717176
17.

Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.

Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K.

J Clin Oncol. 1999 Jan;17(1):19-24.

PMID:
10458213
18.

Prognostic importance of isolated peritumoral lymphangiosis carcinomatosa in lymph-node-negative colorectal carcinoma.

Meyer W, Awad-Allah A, Steinhäuser BB, Jurowich C, Kaiser A, Gebhardt C.

Langenbecks Arch Surg. 2001 Mar;386(2):124-31.

PMID:
11374045
19.

Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.

García-Sáenz JA, Sáenz MC, González L, Pérez-Segura P, Puente J, López-Tarruella S, Sastre J, Casado A, López-Asenjo JG, Díaz-Rubio E.

Clin Transl Oncol. 2006 Sep;8(9):676-80.

PMID:
17005470
20.

Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.

Sanchez-Cespedes M, Esteller M, Hibi K, Cope FO, Westra WH, Piantadosi S, Herman JG, Jen J, Sidransky D.

Clin Cancer Res. 1999 Sep;5(9):2450-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk